Skip to main content
. 2012 Oct 12;40(22):11189–11201. doi: 10.1093/nar/gks918

Table 3.

Distribution of clinical dengue virus sequencing datasets

Drug Placebo Total
DENV1 8 (19) 11 (22) 19 (41)
DENV2 5 (11) 2 (4) 7 (15)
DENV3 2 (5) 2 (4) 4 (9)
Total 15 (35) 15 (30) 30 (65)

The samples analyzed here were collected as part of a drug-trial study for the nucleoside-analog Balapiravir (31). Numbers in parentheses report the total number of samples sequenced, while un-parenthesized numbers report the number of pairs (a pre- and a post-dose sample) that were sequenced.